Studies on the activation of the pre-kininogenin-kininogenin (pre-kallikrein-kallikrein) system by sulfated polysaccharides and kaolin

The activation of pre-kininogenin to kininogenin (pre-kallikrein to kallikrein) is one of the steps in the series of reactions of a complex system, linked also to fibrinolysis and coagulation, that leads to kinin release in plasma (See Cochrane et al., 1976; Wuepper, 1976; Kaplan et al., 1976; Kaplan et al., 1976). For human plasma, a test using kaolin as activator and measuring kallikrein activity with the chromogenic substrate Chromozym PK (Nα-benzoyl-prolyl-phenylalanyl-arginyl-nitroanilide, Pentapharm, Basle) is routinely employed. The purpose of this paper is to further study the mechanism of this activation, by means of different activators and using as inhibitor hexadimethrine bromide (Polybrene). Besides kaolin, sulfated polysaccharides, such as heparin and cellulose sulfate are able to activate pre-kininogenin to kininogenin. Hexadimethrine as expected, inhibited the activation by heparin and also that by cellulose sulfate. The activation by kaolin however followed a different pattern suggesting, at least partially, a different mode of action of this activator. © 1979.

Instalação de uma rede mesh metropolitana utilizando o padrão IEEE 802.11a e implementação do serviço Voip (Wman-Voip)

Pós-graduação em Engenharia Elétrica - FEIS

Raman Lidar monitors emissions from sugar cane fires in the State of São Paulo: a pilot-project integrating radar, sodar, aerosol and gas observations

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Revision of the Neotropical moth genera Mallodeta Butler and Erruca Walker, revalidated (Noctuidae, Arctiinae, Arctiini, Euchromiina)

Mallodeta Butler and Erruca Walker, revalidated, are redescribed and revised. Mallodeta henceforth includes only its type-species, Glaucopis (Lycorea) clavata Walker, and Erruca is resurrected with seven species: E. deyrolii Walker (type-species), E. consors (Walker), new combination, E. erythrarchos (Walker), new combination, E. cardinalis (Hampson), new combination, E. hanga (Herrich-Schaffer), new combination, E. cruenta (Perty), new combination and E. sanguipuncta (Druce), new combination. Six new synonyms are established, four specific and two generic (junior synonyms in parentheses): Zygaena capistrata Fabricius (=Mallodeta cubana Gaede), Glaucopis (Lycorea) clavata Walker (=M. simplex Rothschild), Erruca deyrolii Walker (=Laemocharis aecyra Herrich-Schaffer and Glaucopis (Hyda) sortita Walker), and Erruca Walker (=Aristodaema Wallengren and Rezia Kirby). Lectotypes are designated to the following species: Erruca deyrolii Walker, Laemocharis deyrollei Herrich-Schaffer, Laemocharis hanga Herrich-Schaffer, Laemocharis aecyra Herrich-Schaffer, Laemocharis norma Herrich-Schaffer, Cosmosoma cardinalis Hampson and Mallodeta sanguipuncta Druce. Illustrations of adults and male and female genitalia of Mallodeta and Erruca are provided, as well as a key to the species of the latter.

Revision of Hista Oiticica (Lepidoptera: Castniidae) and discussion on the validity of its subspecies

Diurnal Lepidoptera tend to have colorful and conspicuous wing patterns, which is the reason the first classifications of day-flying moths and butterflies were based mainly on wing color and pattern characters. This is the case with the Neotropical Castniidae, which are usually large and colorful day-flying moths. One classification listed 134 species in 32 genera while an alternate classification recognized 81 species. In this paper we examine the taxonomic structure of the genus Hista Oiticica. It is the purpose of this paper to evaluate taxonomically useful characters besides wing pattern with the goal of classifying the taxa of Hista rather than classifying the variation of its wing pattern. In so doing, the results resolve the differences between the two proposed classifications of Hista. In addition, a lectotype is designated for Castnia boisduvalii Walker, 1854 (new synonym of Castnia fabricii Swainson, 1823) to ensure the stability of the name. Other new synonyms are proposed for C. fabricii (C. papagaya Westwood, 1877) and Castnia hegemon Kollar, 1839 (C. menetriesi Boisduval, [1875] and C. hegemon variegata Rothschild, 1919).

Hypergraphs with many Kneser colorings

For fixed positive integers r, k and E with 1 <= l < r and an r-uniform hypergraph H, let kappa(H, k, l) denote the number of k-colorings of the set of hyperedges of H for which any two hyperedges in the same color class intersect in at least l elements. Consider the function KC(n, r, k, l) = max(H epsilon Hn) kappa(H, k, l), where the maximum runs over the family H-n of all r-uniform hypergraphs on n vertices. In this paper, we determine the asymptotic behavior of the function KC(n, r, k, l) for every fixed r, k and l and describe the extremal hypergraphs. This variant of a problem of Erdos and Rothschild, who considered edge colorings of graphs without a monochromatic triangle, is related to the Erdos-Ko-Rado Theorem (Erdos et al., 1961 [8]) on intersecting systems of sets. (C) 2011 Elsevier Ltd. All rights reserved.

Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study

Abstract Background Photodynamic therapy (PDT) using 5-aminolevulinic acid (5-ALA) is a skin cancer therapy that still has limitations due to the low penetration of this drug into the skin. We have proposed in this work a delivery system for 5-ALA based on liposomes having lipid composition similar to the mammalian stratum corneum (SCLLs) in order to optimize its skin delivery in Photodynamic Therapy (PDT) of skin cancers. Methods SCLLs were obtained by reverse phase evaporation technique and size distribution of the vesicles was determinated by photon correlation spectroscopy. In vitro permeation profile was characterized using hairless mouse skin mounted in modified Franz diffusion cell. Results Size exclusion chromatography on gel filtration confirmed vesicle formation. SCLLs obtained by presented a degree of encapsulation of 5-ALA around 5.7%. A distribution of vesicle size centering at around 500 nm and 400 nm respectively for SCLLs and SCLLs containing 5-ALA was found. In vitro 5-ALA permeation study showed that SCLLs preparations presented higher skin retention significantly (p < 0.05) on the epidermis without SC + dermis, with a decreasing of skin permeation compared to aqueous solution. Conclusions The in vitro delivery performance provided by SCLLs lead to consider this systems adequate for the 5-ALA-PDT of skin cancer, since SCLLs have delivered 5-ALA to the target skin layers (viable epidermis + dermis) to be treated by topical PDT of skin cancer.

Gefitinib in Combination with Irradiation with or Without Cisplatin in Patients with Inoperable Stage III Non-Small Cell Lung Cancer: A Phase I Trial

To establish the feasibility and tolerability of gefitinib (ZD1839, Iressa) with radiation (RT) or concurrent chemoradiation (CRT) with cisplatin (CDDP) in patients with advanced non-small cell lung cancer (NSCLC).

The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non-small cell lung cancer

Inhibitor of differentiation 1 (ID1) plays a role in cellular differentiation, proliferation, angiogenesis and tumor invasion. As shown recently, ID1 is positively regulated by the tyrosine kinase SRC in lung carcinoma cell lines and with that appears as a potential new therapeutic target in non-small cell carcinoma (NSCLC). To substantiate this hypothesis we examined ID1, SRC and matrix metalloproteinase-9 (MMP-9) immunohistochemically in human NSCLC specimens.

A novel fusion toxin derived from an EpCAM-specific designed ankyrin repeat protein has potent antitumor activity

Designed ankyrin repeat proteins (DARPins) hold great promise as a new class of binding molecules to overcome the limitations of antibodies for biomedical applications. Here, we assessed the potential of an epithelial cell adhesion molecule (EpCAM)-specific DARPin (Ec4) for tumor targeting as a fusion toxin with Pseudomonas aeruginosa exotoxin A.

Src inhibitors in lung cancer: current status and future directions

Src tyrosine kinases regulate multiple genetic and signaling pathways involved in the proliferation, survival, angiogenesis, invasion, and migration of various types of cancer cells They are frequently expressed and activated in many cancer types, including lung cancer. Several Src inhibitors, including dasatinib, saracatinib, bosutinib, and KX2-391, are currently being investigated in clinical trials. Preliminary results of the use of single-agent Src inhibitors in unselected patients with lung cancer show that these inhibitors have a favorable safety profile and anticancer activity. Their combination with cytotoxic chemotherapy, other targeted therapy, and radiation therapy is currently being explored. In this review, we summarize the rationale for and the current status of Src inhibitor development and discuss future directions based on emerging preclinical data.